In vitro antibiotic susceptibility testing of clinical isolates of Mycoplasma penetrans from patients with AIDS.

AUTOR(ES)

Hayes, M M

RESUMO

In vitro susceptibilities of Mycoplasma penetrans were determined. MICs and MBCs were determined. The MICs at which 50% of the isolates are inhibited (micrograms per milliliter) for broth dilution testing were as follows: azithromycin, 0.039; chloramphenicol, 0.625; ciprofloxacin, 0.156; clindamycin, 0.078; doxycycline, 0.312; erythromycin, 0.312; gentamicin. > 10; levofloxacin, 0.078; lincomycin, 0.625; streptomycin, > 10; and tetracycline, 1.25. Bactericidal activity was significant only for ciprofloxacin (MBC at which 50% of the isolates are killed, 0.312 microgram/ml) and levofloxacin (MBC at which 50% of the isolates are killed, 0.312 microgram/ml).

Documentos Relacionados

• Virulence of Rhodococcus equi isolates from patients with and without AIDS.
• In vitro susceptibility of Clostridium difficile isolates from patients with antibiotic-associated diarrhea or colitis.
• In vitro antibiotic susceptibility testing of different strains of Mycoplasma fermentans isolated from a variety of sources.
• Fluconazole Susceptibility Testing of Cryptococcus neoformans: Comparison of Two Broth Microdilution Methods and Clinical Correlates among Isolates from Ugandan AIDS Patients
• In vitro susceptibility testing and DNA typing of Saccharomyces cerevisiae clinical isolates.